LaPlace to the rescue! Unfortunate patient with torrential TR from bi-leaflet flail of the tricuspid valve. No commercial options but wonderfully (and simply!) treated with the LaPlace Transcatheter tricuspid valve via compassionate use pathway at Beth Israel Deaconess.
Excited to have started commercial M3 Transcatheter mitral valve replacement therapy at Beth Israel Deaconess Medical Center. First two patients without any other options treated and home! Great solution for those in need.
Incredibly excited to welcome @jamiemccabeMD to @BIDMChealth as Section Chief of Structural Heart Therapies; and to @SmithBIDMC where he will be the inaugural director of a new center devoted to innovation in cardiac technologies and techniques.
Just published - the 2nd clinical series of SESAME patients in the world. Validates the efficacy and safety results first published by the Emory group. Over 200 patients now treated world wide.
@gb_mackensen@AdamGreenbaumMD@CathElectroSurg@DavidElison1 https://t.co/G9uxKyjO0H
Bittersweet day to finish my last case with one of the 🐐 @jamiemccabeMD . Did 1) subaortic membrane SESAME, 2) ARCTIC TMVR, and 3) TTVR ViV + Mitral TEER, all before 2:30pm. His talent and creativity will certainly be missed! Best of 🍀 in Boston! @UWMedHeart
📷:@gb_mackensen
https://t.co/EwMnCEQbcN
ŌNŌ helps again….
The exciting report below describes non-surgical LEFT ATRIAL tumor removal via ATRIAL SEPTECTOMY using the combination of Electrosurgery techniques + TEE imaging + ŌNŌ.
@jamiemccabeMD
ŌNŌ helps again.
Amazing case combining electrosurgical techniques, TEE imaging, and ŌNŌ for NON-SURGICAL atrial septectomy and left atrial myxoma removal.
@jamiemccabeMD@gb_mackensen@UWCardiology
https://t.co/EwMnCEQJ2l
It’s not just gear and technique. It’s about owning your worst day in the lab. Structural/Coronary/Human. The only course that dives into complications from both ends of the table. Come for the chaos. Stay for the clarity. @DrBillLombardi@jamiemccabeMD@KateKearney4@LAzzaliniMD
Psyched for Seattle Complications Course - full day of structural complications added for the first time! Structural agenda will be Thurs 7/10. Access, legal & life issues Fri 7/11. Coronary program on Sat 7/12. Come for any 2 days that fit you or all 3! https://t.co/Tj6hpsCfI9
Watch Now! OPCI Journal Club “Transcatheter Mitral Valve Replacement Using Annular Reduction by Cinching With TEER in the Commissure (ARCTIC)” presented by @jamiemccabeMD. Panelists @CathElectroSurg and Drs. Matthew Henry, Newell Robinson, and Lin Wang.
https://t.co/Wiurwq7YVs
How long do you keep patients supine following standard transfemoral TAVR? Guess what our single center RCT on the topic suggests…
https://t.co/S2kEyRaRkh
Thanks to Sydney Valves for the live case invite! Not a candidate for any of our 3 TMVR trials. Valve was 41x25 with severe MAC (not rheumatic) & neoLVOT was 149. Hence the ARCTIC TMVR + LAMPOON. Awesome imaging by @RichardSheuMD
Our structural team @UWMedHeart successfully broadcast a live case of LAMPOON ARCTIC TMVR for severe rheumatic MS to @EPIC_meeting, masterfully executed by @jamiemccabeMD & @DavidElison1. Constantly inspired by our team's drive to push boundaries and expand what's possible.
💡 Master complications management with Dr. James McCabe at #CompCourse2025!
This year, we’re going beyond coronary complications – diving into structural complications management like never before. Get the expert insights, real-time strategies, and hands-on learning you need to tackle even the toughest cases.
Take advantage of early-bird pricing through April 29, 2025. Secure your spot now! https://t.co/GO94byzX1O
#CardioX #CardioTwitter #CardioEd #CardioResearch @KateKearney4@DrBillLombardi@jamiemccabeMD@BurkhoffMd@djc795@georgedangas@jgranadacrf@MartyBLeon@Drroxmehran@sahilparikhmd@triciarawh
In case you were wondering what size LA mass could be removed with SEATTLE procedure and Inari aspiration cath for combo myxoma with associated clot, here’s an example: